AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JAN 8 - (NewsRx.com & NewsRx.net) -- MedMira, Inc., (MIR) announced that it has reached a strategic investment agreement with its American distributor, American Health Diagnostics, LLC, (AHD).
This agreement contemplates the issuance of 150,000 common shares with an additional 2 warrants for each share purchased at an exercise price of $1.50 for a 2-year period. This agreement is subject to applicable securities laws and approval by the TSX Venture Exchange.
AHD is also MedMira's exclusive distributor in the United States, and has previously ordered 500,000 Reveal Rapid HIV-1 Antibody Tests to be delivered following receipt of premarket approval by the United States Food and Drug Administration (FDA).
To date, MedMira has not received any notification from the FDA as to when the approval may be expected. MedMira's tests will be distributed through an agreement with Allegiance Healthcare, a subsidiary of Cardinal Health, one of the world's leading healthcare ...
Source: HighBeam Research, In vitro diagnostic test developer completes agreement with American...